TM
Travis C Mickle
President & CEODirector

Travis C Mickle insider trades: Kempharm (KMPH) stock purchases

President & CEO, Kempharm Last trade May 25, 2022 23 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
14
Open-market trades
since 2016
1
Company
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Travis reports to the SEC

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 25, 2022KMPH↑ Buy$44K
May 25, 2022KMPH↑ Buy$13K
Nov 18, 2021KMPH↑ Buy$19K
Aug 30, 2021KMPH↑ Buy$45K
Jun 14, 2021KMPH↑ Buy$22K
Jun 2, 2020KMPH↑ Buy$21K
Mar 5, 2020KMPH↑ Buy$8K
Sep 24, 2019KMPH↑ Buy$39K
Oct 12, 2018KMPH↑ Buy$13K
Jun 20, 2017KMPH↑ Buy$28K
Mar 22, 2017KMPH↑ Buy$8K
Aug 17, 2016KMPH↑ Buy$25K
Mar 29, 2016KMPH↑ Buy$30K
Mar 29, 2016KMPH↑ Buy$6K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Travis C Mickle's insider trades

Travis C Mickle is President & CEO at Kempharm (KMPH). Since Mar 29, 2016, Travis has reported 14 open-market purchases worth $319K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (9 filings), gifts (4 filings), other transactions (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KMPH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.